Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature ...

Food and Drug Administration Commissioner Marty Makary is resigning from his role, according to an administration source ...

The tobacco industry chalked up another win on Friday with a new policy announced by the Food and Drug Administration that ...

Doctors and insurers are battling to reshape the controversial No Surprises Act arbitration process, which has long ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

Addiction medicine offers a useful framework. Many people use substances without developing addiction. The difference often ...

Late last month, Utah’s Medical Licensing Board called for the immediate suspension of the state’s pilot program with the AI ...

Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. Bob Herman covers health insurance, government programs, hospitals, ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Plans to oust Makary, a looming Supreme Court deadline on mifepristone, and other health news from Morning Rounds ...

Last year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump ...

The WHO held a press conference about the situation Thursday. Here are five key takeaways: At present no one who is ill is ...